公司資料
Longboard Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- LBPH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for LBPH.
公司概覽
業務概覽
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck. Its story centered on a targeted CNS asset and clinical differentiation.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ prior to acquisition, Longboard sat in specialty neuroscience biotechnology.
商業模式特徵
The business depended on clinical data, CNS differentiation, and the strategic value of its pipeline.
生技產業定位
Longboard was a focused neuroscience catalyst name and now belongs to biotech M&A history.
未來催化劑
- Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work. The company is still very much a one-program story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。